1006: Access to buprenorphine in pregnancy: Minimizing barriers for patients

Opiate use disorder (OUD) has reached epidemic incidence with disproportionate mortality in women. Although treatment for OUD is effective for decreasing maternal and obstetric morbidity, there are many barriers to accessing care. We aimed to contact all of the buprenorphine (bup) and methadone providers listed on the Substance Abuse and Mental Health Administration (SAMHSA) website to describe the treatment availability for pregnant patients in Missouri (MO) and Illinois (IL).
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Poster Session V Source Type: research